Overweight Clinical Trial
Official title:
A New Concept for Lifestyle Change, Dietary Advice on Prescription (DAP) in Combination With Motivational Interviewing (MI), Social Support and Mobile Services
The aim of the study is to evaluate self-reported adherence to and the effects of an
intervention model consisting of individualized prescribed dietary advice (DAP) in
combination with Motivational Interviewing (MI), social support and mobile services in obese
patients in primary health care. The specific aim is to relate effects of the intervention
model to self-reported health, biomarkers for coronary heart disease, diabetes, some cancer
forms, sleep duration and quality, health economy, oral health, dietary intake and physical
activity.
This is a two-armed randomized controlled study. The arms are: 1) Control group (care as
usual) and 2) Experimental group (MoR). The volunteers will be consecutively, for each sex,
randomized to the experimental and the control group, respectively.
The experimental group will receive DAP together with Motivational interviewing up to six
months after the start of the study. From six months up to 24 months the participants will
receive social support online and mobile services.
The control group will receive dietary information according to the "Habo model". The
previously mentioned diet will be recommended to both the control group and the experimental
group since it is the method in which the investigators give the information they want to
study and not the diet per se. Thus, it is only the way the investigators give dietary
information that differs between the groups.
The study also includes qualitative interviews. The aim of these studies is to gain
understanding of patients' and health professionals' experience and attitudes around food,
lifestyle and support functions associated with dietary change. The sampling approach
involves the purposeful selection of cases with a wide range of variation, which means that
the researcher selects people who are able to provide rich information about the current
issue. To achieve diversity, it is useful that both women and men are involved in the
studies, as well as people of different ages and with different experiences of providing or
receiving dietary advice. About 15-20 people will participate in each interview study.
The investigators assume a difference in BMI (body mass index; kg/m x m) of 2 units, a
standard deviation of 4.5 units, a power of 80 %, an alfa error of 5 % I a two-tailed test,
the investigators would need at least 80 individuals in the experimental group and in the
control group, respectively.
With 80 individuals in each group and the assumption of 5 % adherence (4 individuals) in the
control group, the investigators would be able to detect an adherence of 21 % or higher (at
least 17 individuals) in the experimental group with 80 % power. The alfa error is set to 5
% in a two-tailed test with the null hypothesis that the adherence is the same in both
groups.
Therefore the investigators plan a study with at least 100 individuals in each group and
assume that 20 % will not complete the study.
The evaluation of the quantitative studies will be performed in three ways: 1) Process
evaluation, that will focus on intermediate outcomes such as knowledge, attitudes,
motivation and readiness for change. 2) Effect evaluation will be used to evaluate the
effect of the intervention programme on the subjects' behavior such as dietary intake and
physical activity level. 3) Outcome evaluation will measure the total effect of the
intervention programme, in this case variables that measures indicators for health and
disease, such as SF-36, EQ-5D, SHIS, serum cholesterol, blood pressure, BMI, waist
circumference etc.
Intention-to-treat (ITT) analysis will be used to assess effects on outcome measures.
Variables not normally distributed will be logarithmically transformed. Paired t-test will
be used to assess change within groups and unpaired t-tests to compare mean changes between
groups. Non-parametric statistics, Wilcoxon Signed Ranks Test and Mann-Whitney U-Test will
be used for ordinal data such as questionnaires. Two-tailed tests will be used and a p-value
less than 0.05 will be considered statistically significant.
Qualitative data will be analyzed by content analysis.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Terminated |
NCT03299881 -
Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss
|
N/A | |
| Completed |
NCT02805478 -
Fat-Associated Cardiovascular Organ Dysfunction
|
||
| Active, not recruiting |
NCT02558920 -
Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
|
||
| Completed |
NCT03759743 -
Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject
|
N/A | |
| Completed |
NCT03610958 -
Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.
|
N/A | |
| Completed |
NCT03678766 -
CHARGE: Controlling Hunger and ReGulating Eating
|
N/A | |
| Completed |
NCT04430465 -
Effects of Wholegrains on Children's Health (KORN)
|
N/A | |
| Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
| Completed |
NCT05376865 -
Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers
|
N/A | |
| Completed |
NCT03625427 -
Effect of Palmitoleic Acid on C-reactive Protein
|
N/A | |
| Active, not recruiting |
NCT03435445 -
Online Platform for Healthy Weight Loss (POEmaS)
|
N/A | |
| Enrolling by invitation |
NCT05576116 -
Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics
|
N/A | |
| Recruiting |
NCT05249465 -
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
|
N/A | |
| Active, not recruiting |
NCT06023095 -
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
|
Phase 1 | |
| Completed |
NCT03648892 -
Brain Dopamine Function in Human Obesity
|
Early Phase 1 | |
| Not yet recruiting |
NCT05751993 -
Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions
|
N/A | |
| Recruiting |
NCT02887950 -
Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause
|
N/A | |
| Completed |
NCT03097237 -
High Fiber Rye Foods for Weight and Body Fat Reduction
|
N/A | |
| Terminated |
NCT02796144 -
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
|
Phase 4 |